Publications by authors named "Susano Lara-Vaca"
Background And Aim: Obesity increases the risk of atrial fibrillation (AF) while it may impact the outcome of patients with AF. The clinical implications of this relationship are not completely clear. We aimed to analyze the association of traditional anthropometric measures of excessive adiposity with 12 month case fatality rate (CFR) in patients with AF.
View Article and Find Full Text PDFAnticoagulation Therapy by Age and Embolic Risk for Nonvalvular Atrial Fibrillation in Mexico, an Upper-Middle-Income Country: The CARMEN-AF Registry.
Glob Heart
April 2020
Background: Documenting the patterns of oral anticoagulation therapy (OAT) is essential to prevent thromboembolic complications of nonvalvular atrial fibrillation (NVAF).
Objective: To report the patterns of OAT according to age and thromboembolic risk in patients included in CARMEN-AF, a nationwide registry of NVAF in Mexico, an upper middle-income country.
Material And Methods: There were 1,423 consecutive patients ≥18 years old and with at least one thromboembolic risk factor enrolled in the CARMEN-AF Registry at their regular clinical visit during a three-year period.
Background: Placing the right ventricular pacing electrode in different places than the apex is less deleterious to the ejection fraction and left ventricular synchrony. Currently it is not defined which non apical site is better alternative. The aim of this paper was to determine if there is a difference in systolic function and left ventricular synchrony with stimulation of medial septum or outflow tract of the right ventricle in patients with atrioventricular block and pacemaker device.
View Article and Find Full Text PDFArticle Synopsis
- The Sociedad Mexicana de Electrofisiología y Estimulación Cardiaca (SOMEEC) organized a multidisciplinary meeting of experts to discuss the effects of atrial fibrillation on stroke and review current scientific evidence.
- The meeting included cardiology, electrophysiology, neurology, and hematology specialists who shared their knowledge to improve understanding and decision-making regarding treatment options.
- The resulting document compiles the best available evidence on managing nonvalvular atrial fibrillation and associated conditions, providing comparative treatment and follow-up schemes for healthcare professionals.
Introduction: The Mexican Registry of Atrial Fibrillation (ReMeFa) is the first national multicenter registry with one-year clinical follow-up on the treatment of atrial fibrillation (AF) in newly diagnosed patients.
Objective: To describe the demographics and treatment modalities for rhythm control (RC) strategy or heart rate (HR) control in patients with AF treated by cardiologists. A secondary objective was to prospectively evaluate the status of AF according to the chosen strategy; sinus rhythm in RC and mean ventricular rate at rest ≤ 80 bpm in HR, as well as the incidence of clinical outcomes at 12 month follow-up.
Article Synopsis
- Atrial fibrillation (AF) significantly increases the risk of cerebrovascular disease, heart failure, and mortality, with a yearly average ischemic stroke incidence of 5% in patients with non-valvular AF.
- One in six ischemic strokes occurs in individuals with AF, highlighting the importance of early detection and intervention to reduce morbidity and mortality associated with this condition.
- A management guide is being developed to provide healthcare professionals with evidence-based recommendations for the diagnosis, risk assessment, and treatment of patients with atrial fibrillation to improve patient care.
Unlabelled: Atrial fibrillation is the most common arrhythmia, predominantly affecting individuals older than 70 years of age. There is little information about its management in Mexico, for this purpose the Mexican Registry of Atrial Fibrillation (ReMeFa) was designed.
Methods: ReMeFA is a prospective multicentric, observational registry concerning the treatment of atrial fibrillation in Mexico.